Vanberra Signal

GRAIL

Curated by Signal

Developer of a screening platform for circulating tumor DNA to detect cancer

Overview

Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.

Key facts

Founded
2015

Business model

Contact

Open roles

122 roles
  • Marketing Operations Specialist #4987

    Sunnyvale, CA · On-site · Internship

  • Senior Corporate Counsel, Compliance (Healthcare) #4927

    Sunnyvale, CA · On-site · Internship

  • Director / Associate Director, International Regulatory Affairs #4809

    Sunnyvale, CA · On-site · Internship

+ 119 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Develops & manufactures orodispersible formulations of highly prescribed high-dose medications using proprietary drug delivery systems.

    Life Sciences TechnologyLanghorne, United States
  • AI based retinal image analysis for diabetic retinopathy

    Life Sciences TechnologyLos Angeles, United States
  • Provider of dietary supplement products for the treatment of menopause and PMS symptoms

    Life Sciences TechnologyHarrison, United States

About GRAIL

What does GRAIL do?

Developer of a screening platform for circulating tumor DNA to detect cancer.

Where is GRAIL headquartered?

GRAIL is headquartered in Menlo Park, United States.

When was GRAIL founded?

GRAIL was founded in 2015.

Which sector is GRAIL in?

GRAIL operates in Life Sciences Technology.

Who are GRAIL's competitors?

Companies similar to GRAIL include Aprecia Pharmaceuticals, Eyenuk, and Bonafide.

Is GRAIL hiring?

Yes. GRAIL has 122 open roles listed on Vanberra Signal.